Developing an Intervention to Optimize Virtual Care Adoption for COPD Management (NCT05986214)
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management (CDA 21-187)
🩺 Plain-English Summary (8th-Grade Level)
VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions like chronic obstructive pulmonary disease (COPD). However, adoption of many VC services has been slow. Lack of awareness about these services is one of the most prominent patient- and healthcare team-facing barriers to adopting VC. This study will develop, refine, and pilot a stakeholder-informed multicomponent implementation strategy to support adoption of VC, referred to as VC-OPTIONS (Virtual Care for Chronic Obstructive Pulmonary Disease Adoption Support). This feasibility trial will pilot the VC-OPTIONS implementation strategy to assess feasibility and acceptability and gather preliminary effectiveness data to inform a larger hybrid effectiveness-implementation trial. The core component of VC-OPTIONS will be the provision of information via VA's Annie texting program to empower patients with knowledge about the array of VC services and how they can be used to support COPD management. It is hypothesized that this strategy will be acceptable and feasible. This work will improve patient and team awareness of and communication about VC services, and support patient access to VC services for COPD management.
Who can join: Review the eligibility criteria below.
Location: VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts
Age range: 40 Years
🧪 Interventions in This Study
- VC-OPTIONS (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (781) 687-4766
Email: stephanie.robinson5@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Obstructive Pulmonary Disease
- Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects — Hershey, Pennsylvania
- A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Chandler, Arizona
- Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD — Miami, Florida
- A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD — Bakersfield, California
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease — Birmingham, Alabama
Explore by condition: All Chronic Obstructive Pulmonary Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.